What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!

13/09/2015 - 1 minute

Monday: A report said that the total value of crowdfunded Biotech projects from within the EU since 2010 is €23M.

 

Tuesday: Researchers from University of Leeds unraveled the mechanism of cancer-targeting effects of Wasp venom.

 

Wednesday: Kymab has been listed in the Sunday Times Tech Track ‘One’s to Watch’ 2015 just this month!

Thursday: CureVac just announced the opening of its subsidiary in Boston and a research collaboration to develop a mRNA-based HIV treatment.

Friday: Cambridge biotech leader Abcam and Horizon Discovery finally came together to partner up on antibody research

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member